Baidu
map

“十四五”卫生发展规划九大关键词:国家医学中心、区域医疗中心、县域医共体、互联网+医疗、中医药传承……

2020-10-09 新华网 新华网

9月22日,习近平总书记主持召开教育文化卫生体育领域专家代表座谈会并发表重要讲话,就“十四五”时期经济社会发展听取意见和建议。未来,县域医共体建设、中医药传承创新发展、加快互联

9月22日,习近平总书记主持召开教育文化卫生体育领域专家代表座谈会并发表重要讲话,就“十四五”时期经济社会发展听取意见和建议。未来,县域医共体建设、中医药传承创新发展、加快互联网+医疗健康发展、健全分级诊疗制度,都将是重点任务。

▲来源:新华网

什么是十四五规划?

中华人民共和国国民经济和社会发展第十四个五年规划纲要,简称“十四五”规划。

2020年7月30日,中共中央政治局召开会议,决定2020年10月在北京召开中国共产党第十九届中央委员会第五次全体会议,研究关于制定国民经济和社会发展第十四个五年规划。我国将于2021年开始实施“十四五”规划。

中共中央总书记、国家主席、中央军委主席习近平近日对“十四五”规划编制工作作出重要指示强调,编制和实施国民经济和社会发展五年规划,是我们党治国理政的重要方式。五年规划编制涉及经济和社会发展方方面面,同人民群众生产生活息息相关,要开门问策、集思广益,把加强顶层设计和坚持问计于民统一起来,鼓励广大人民群众和社会各界以各种方式为“十四五”规划建言献策,切实把社会期盼、群众智慧、专家意见、基层经验充分吸收到“十四五”规划编制中来,齐心协力把“十四五”规划编制好。

“十四五”规划的四大风向

在卫生健康方面,习近平提到,研究谋划“十四五”时期卫生健康发展,要站位全局、着眼长远,聚焦面临的老难题和新挑战,拿出实招硬招,全面推进健康中国建设。主要提到了以下几点:

第一,加快完善卫生健康制度体系,增强人民健康的制度保障。

要把人民健康放在优先发展战略地位,努力全方位全周期保障人民健康,加快建立完善制度体系,保障公共卫生安全,加快形成有利于健康的生活方式、生产方式、经济社会发展模式和治理模式,实现健康和经济社会良性协调发展。

第二,构建强大公共卫生体系,切实提高应对突发重大公共卫生事件的能力和水平。

要坚定不移贯彻预防为主方针,坚持防治结合、联防联控、群防群控,建立稳定的公共卫生事业投入机制,加快理顺体制机制、完善基础设施、提升专业能力,加大疾病预防控制体系改革力度,增强早期监测预警能力、快速检测能力、应急处置能力、综合救治能力

第三,坚持开展爱国卫生运动,创新突发疾病预防手段。

要在做好常态化疫情防控的同时,聚焦影响人民健康的重大疾病和主要问题,加快实施健康中国行动,深入开展爱国卫生运动,完善国民健康促进政策,创新社会动员机制,健全健康教育制度,强化重点人群和重大疾病综合防控,从源头上预防和控制重大疾病,实现从以治病为中心转向以健康为中心

第四,要坚持基本医疗卫生事业的公益性,坚持政府主导,强化政府对卫生健康的领导责任、投入保障责任、管理责任、监督责任。

“十四五”卫生事业发展的九大关键任务

第一,要加大公立医疗卫生机构建设力度,加强国家医学中心、区域医疗中心、县级医院建设,加快优质医疗资源扩容和区域均衡布局,让广大人民群众就近享有公平可及、系统连续的预防、治疗、康复、健康促进等健康服务。

第二,要推进县域医共体建设,改善基层基础设施条件,落实乡村医生待遇,提高基层防病治病和健康管理的能力。

第三,要促进中医药传承创新发展,坚持中西医并重和优势互补,建立符合中医药特点的服务体系、服务模式、人才培养模式,发挥中医药的独特优势。

第四,要集中力量开展关键核心技术攻关,解决一批药品、医疗器械、疫苗等领域“卡脖子”问题。

第五,要高度重视新一代信息技术应用,加快“互联网+医疗健康”发展

第六,要深化医疗卫生体制改革,加快健全分级诊疗制度、现代医院管理制度、全民医保制度、药品供应保障制度、综合监管制度,合理制定并落实公立医疗卫生机构人员编制标准并建立动态核增机制。

第七,要大力弘扬伟大抗疫精神,在全社会营造尊医重卫的良好风尚。

第八,要认真总结疫情防控中经过实践检验的经验和模式,用制度形式予以固化。

第九,要加强国际交流合作,完善我国参与国际重特大突发公共卫生事件应对工作机制,履行国际义务,发挥全球抗疫物资最大供应国作用,推动构建人类卫生健康共同体。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (11)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
    2021-03-14 lishizhe
  3. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
    2021-05-20 respect
  4. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
    2020-10-15 691273246

    赚积分

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
    2020-10-11 cathymary
  9. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]
  10. [GetPortalCommentsPageByObjectIdResponse(id=1942778, encodeId=4e831942e7880, content=<a href='/topic/show?id=5b6f34e758e' target=_blank style='color:#2F92EE;'>#医疗中心#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34775, encryptionId=5b6f34e758e, topicName=医疗中心)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1be8234, createdName=sunyl07, createdTime=Wed Jan 06 00:26:40 CST 2021, time=2021-01-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1675596, encodeId=e01216e5596fa, content=<a href='/topic/show?id=8e7d258696c' target=_blank style='color:#2F92EE;'>#传承#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=25869, encryptionId=8e7d258696c, topicName=传承)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=85d827261473, createdName=lishizhe, createdTime=Sun Mar 14 03:26:40 CST 2021, time=2021-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1672529, encodeId=c05d16e252989, content=<a href='/topic/show?id=60819060283' target=_blank style='color:#2F92EE;'>#规划#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90602, encryptionId=60819060283, topicName=规划)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=676926912123, createdName=respect, createdTime=Thu May 20 04:26:40 CST 2021, time=2021-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1913689, encodeId=81761913689ee, content=<a href='/topic/show?id=08933018ea9' target=_blank style='color:#2F92EE;'>#关键词#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=30187, encryptionId=08933018ea9, topicName=关键词)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e5bc315, createdName=Tommy1949, createdTime=Thu Feb 25 17:26:40 CST 2021, time=2021-02-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892219, encodeId=b1808922197f, content=赚积分, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b032823267, createdName=691273246, createdTime=Thu Oct 15 14:26:52 CST 2020, time=2020-10-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1274340, encodeId=e62c12e434047, content=<a href='/topic/show?id=04fd241222d' target=_blank style='color:#2F92EE;'>#互联网#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24122, encryptionId=04fd241222d, topicName=互联网)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2726119, createdName=july_975, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1392803, encodeId=b4a71392803e4, content=<a href='/topic/show?id=c9e03393569' target=_blank style='color:#2F92EE;'>#医共体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=33935, encryptionId=c9e03393569, topicName=医共体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c97a2500111, createdName=thinkibmz_44722594, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1410069, encodeId=1ec614100690f, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438106, encodeId=b5f91438106a3, content=<a href='/topic/show?id=e08c2412394' target=_blank style='color:#2F92EE;'>#互联网+#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24123, encryptionId=e08c2412394, topicName=互联网+)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1620085, encodeId=41dc1620085ef, content=<a href='/topic/show?id=ec5324125e3' target=_blank style='color:#2F92EE;'>#互联网+医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=24125, encryptionId=ec5324125e3, topicName=互联网+医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=631320069238, createdName=yige2010, createdTime=Sun Oct 11 02:26:40 CST 2020, time=2020-10-11, status=1, ipAttribution=)]

相关资讯

一文带你了解全球TOP50的医疗健康企业

“伟大的人不是生下来就伟大的,而是在成长过程中显示其伟大的。”Mario Puzo在《教父》中写到。人如此,企业亦如人。在当下这个技术飙升、财富丰盈的时代里,巨头企业仍然是行业发展的重要参照物以及驱动力。

医疗健康“基本法”实施,社会资本与公立医院的合作将何去何从?

《基本医疗卫生与健康促进法 》(以下简称卫健法)已于2020年6月1日实施,这部法律是卫生健康领域的基础性法律,对于整个卫生健康行业的发展指明了方向。同时,由于该法律与国家此前发布的一些规定和通知有冲

上海黄浦正建设医疗健康领域“新硅谷”,构建三大发展圈层

上海市黄浦区正在建设医疗健康领域“新硅谷”。伴随着上海科创中心建设进入深化推进之年、上海建设亚洲医学中心进入冲刺阶段,黄浦区政府携手瑞金医院,正在思南地区打造一个全新的创新产业园区,即广慈-思南国家转化医学创新产业园区。首届“健康中国思南峰会”5月8日至5月10日在黄浦区召开,记者从会议获知上述消息。峰会由黄浦区人民政府、上海交通大学医学院附属瑞金医院共同主办。会议透露,园区定位于建成国内最高、亚

福布斯医疗健康“30 under 30”榜单出炉,他们为医疗健康带来哪些改变?

今日,美国福布斯(Forbes)杂志公布了2020年的“30 under 30”榜单。医疗健康领域的榜单上包含了初创公司的创始人和着名科学研究机构的科学家等青年才俊。让我们来看一看他们在哪些方面为医疗健康系统带来了革新?

国务院:支持社会资本进入医疗健康、养老家政等服务领域

李克强主持召开国务院常务会议确定支持平台经济健康发展的措施 壮大优结构促升级增就业的新动能部署进一步加强知识产权保护工作 切实保护各类市场主体合法权益国务院总理李克强7月17日主持召开国务院常务会议,确定支持平台经济健康发展的措施,壮大优结构促升级增就业的新动能;部署进一步加强知识产权保护工作,切实保护各类市场主体合法权益。会议指出,互联网平台经济是生产力新的组织方式,是经济发展新动能,对优化资源

北京新基建方案出炉 五项内容涉及医疗健康

6月10日,北京市政府新闻办组织召开北京市新冠肺炎疫情防控工作第111场新闻发布会。会上发布了《关于加快培育壮大新业态新模式促进北京经济高质量发展的若干意见》,以及《北京市加快新型基础设施建设行动方案

Baidu
map
Baidu
map
Baidu
map